This post was originally published on this site

[unable to retrieve full-text content](RTTNews) – Johnson & Johnson (JNJ) has paused the phase III study of its COVID-19 vaccine candidate, JNJ-78436735, due to an unexplained illness in a study participant, Stat News reported, citing a …